Open AccessOncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparison of the Procedure and Outcomes Between the United States and Australia
Author(s) -
Michael J. Carr,
James Sun,
Hidde M. Kroon,
John T. Miura,
Georgia M. Beasley,
Norma E. Farrow,
Paul J. Mosca,
Michael Lowe,
Clara R. Farley,
YoungChul Kim,
Syeda Mahrukh Hussnain Naqvi,
Д. А. Кириченко,
Aishwarya Potdar,
Hala Daou,
Dean Mullen,
Jeffrey M. Farma,
Michael A. Henderson,
David Speakman,
Jonathan Serpell,
Keith A. Delman,
B. Mark Smithers,
Brendon J. Coventry,
Douglas S. Tyler,
John F. Thompson,
Jonathan S. Zager
Publication year - 2020
Publication title -
annals of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.764
H-Index - 173
eISSN - 1534-4681
pISSN - 1068-9265
DOI - 10.1245/s10434-020-09051-y
Subject(s) - surgical oncology , medicine , melanoma , general surgery , medline , surgery , cancer research , political science , law
Isolated limb infusion (ILI) is a minimally invasive procedure for delivering high-dose chemotherapy to extremities affected by locally advanced or in-transit melanoma. This study compared the outcomes of melanoma patients treated with ILI in the United States of America (USA) and Australia (AUS).